Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 551

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Kinase RIP3 Is Dispensable for Normal NF-κBs, Signaling by the B-Cell and T-Cell Receptors, Tumor Necrosis Factor Receptor 1, and Toll-Like Receptors 2 and 4

Open access
Newton, Kim, Sun, Xiaoqing, Dixit, Vishva M.·2004·Molecular and Cellular Biology

Abstract

RIP3 is a member of the RIP kinase family. It is expressed in the embryo and in multiple adult tissues, including most hemopoietic cell lineages. Several studies have implicated RIP3 in the regulation of apoptosis and NF-kappa B signaling, but whether RIP3 promotes or attenuates activation of the NF-kappa B family of transcription factors has been controversial. We have generated RIP3-deficient mice by gene targeting and find RIP3 to be dispensable for normal mouse development. RIP3-deficient cells showed normal sensitivity to a variety of apoptotic stimuli and were indistinguishable from wild-type cells in their ability to activate NF-kappa B signaling in response to the following: human tumor necrosis factor (TNF), which selectively engages mouse TNF receptor 1; cross-linking of the B- or T-cell antigen receptors; peptidoglycan, which activates Toll-like receptor 2; and lipopolysaccharide (LPS), which stimulates Toll-like receptor 4. Consistent with these observations, RIP3-deficient mice exhibited normal antibody production after immunization with a T-dependent antigen and normal interleukin-1 beta (IL-1 beta), IL-6, and TNF production after LPS treatment. Thus, we can exclude RIP3 as an essential modulator of NF-kappa B signaling downstream of several receptor systems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mcb.24.4.1464-1469.2004

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 20

  1. Devin A., 2000, Immunity, 12, 419, 10.1016/S1074-7613(00)80194-6 · DOI · Paper page
  2. Doi T. S., 1997, J. Exp. Med., 185, 953, 10.1084/jem.185.5.953 · DOI · Paper page
  3. Ghosh S., 1998, Annu. Rev. Immunol., 16, 225, 10.1146/annurev.immunol.16.1.225 · DOI · Paper page
  4. Karin M., 1999, Oncogene, 18, 6867, 10.1038/sj.onc.1203219 · DOI · Paper page
  5. Kasof G. M., 2000, FEBS Lett., 473, 285, 10.1016/S0014-5793(00)01473-3 · DOI
  6. Kelliher M. A., 1998, Immunity, 8, 297, 10.1016/S1074-7613(00)80535-X · DOI · Paper page
  7. Köntgen F., 1995, Genes Dev., 9, 1965, 10.1101/gad.9.16.1965 · DOI · Paper page
  8. Lewis M., 1991, Proc. Natl. Acad. Sci. USA, 88, 2830, 10.1073/pnas.88.7.2830 · DOI · Paper page
  9. Newton K., 2003, Curr. Biol., 13, 1247, 10.1016/S0960-9822(03)00458-5 · DOI
  10. Pazdernik N. J., 1999, Mol. Cell. Biol., 19, 6500, 10.1128/MCB.19.10.6500 · DOI
  11. Pohl T., 2002, Proc. Natl. Acad. Sci. USA, 99, 4514, 10.1073/pnas.072071599 · DOI
  12. Pomerantz J. L., 2002, EMBO J., 21, 5184, 10.1093/emboj/cdf505 · DOI
  13. Snapper C. M., 1996, J. Immunol., 156, 183, 10.4049/jimmunol.156.1.183 · DOI · Paper page
  14. Stanger B. Z., 1995, Cell, 81, 513, 10.1016/0092-8674(95)90072-1 · DOI · Paper page
  15. Sun S. C., 1993, Science, 259, 1912, 10.1126/science.8096091 · DOI · Paper page
  16. Sun X., 1999, J. Biol. Chem., 274, 16871, 10.1074/jbc.274.24.16871 · DOI
  17. Sun X., 2002, J. Biol. Chem., 277, 9505, 10.1074/jbc.M109488200 · DOI · Paper page
  18. Takeuchi O., 1999, Immunity, 11, 443, 10.1016/S1074-7613(00)80119-3 · DOI · Paper page
  19. Yu P. W., 1999, Curr. Biol., 9, 539, 10.1016/S0960-9822(99)80239-5 · DOI
  20. Zheng Y., 2003, J. Exp. Med., 197, 861, 10.1084/jem.20021610 · DOI

Cited by

Metadata

Authors
Newton, K., Sun, X., & Dixit, V. M.
Venue
Molecular and Cellular Biology
Published
2004-02-01
Volume
24
Issue
4
Pages
1464-1469
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2130776456
Cited by
551
References
1
FWCI
1.59
Type
journal article
Language
en
Open access
green
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.